PANAZEP LS

1. All Details: Specifications
Active Therapeutic Combination: Paroxetine Hydrochloride IP equivalent to Paroxetine 12.5 mg (as extended-release form) and Clonazepam IP 0.25 mg.
Dosage Form: Film-coated tablets.
Storage Requirements: Store at room temperature, protected from light & moisture. Keep out of reach of children.
Legal & Safety Classification: Schedule H Prescription Drug – Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only (signified by the ‘NRx’ prefix and the bright red warning block).
Manufacturing License Number: M.L.: 374/DR/Mfg/2013
Batch Identifier: B. No. GTF2392A
Retail Pricing Information: Maximum Retail Price (M.R.P.) is ₹116.00 per 10 tablets (Inclusive of all taxes).
2. General
Brand: SUN (Sun Pharma Laboratories Ltd.)
Name: Panazep LS (Paroxetine Extended Release and Clonazepam Tablets)
Quantity: 10 Tablets per blister pack strip.
Type / Form Factor: Pharmaceutical Tablets (Film-coated form factor).
Maximum Shelf Life: 24 months (2 years). The packaging explicitly logs an expiration date (EXP.) of 07/2026.
Food Preference / FSSAI: Not Applicable. This product is a prescription psychotropic medication manufactured under state drug licensing guidelines. It is not a food product or dietary supplement, meaning it does not fall under FSSAI jurisdiction or possess standard dietary preference markings.
3. Product Details: Ingredients
Active Composition: Each film-coated tablet contains:
Paroxetine Hydrochloride IP equivalent to Paroxetine: 12.5 mg (as extended release)
Clonazepam IP: 0.25 mg
Inactive Composition: Excipients: q.s. (Quantity Sufficient).
Approved Color Additives: Contains Ferric Oxide (Yellow) USP-NF, Ferric Oxide (Red) USP-NF, and Titanium Dioxide IP.
4. Directions: How to Use
Dosage: As directed by the Psychiatrist.
Administration Guidelines: The tablet should be swallowed whole and not to be chewed or crushed (to prevent disturbing the extended-release mechanism).
5. Description
Overview: Panazep LS is a combination prescription neuro-psychiatric medication. It combines an SSRI antidepressant (Paroxetine) designed for steady, extended release with a low-dose benzodiazepine anxiolytic (Clonazepam) to concurrently manage panic disorders, anxiety symptoms, and comorbid depression under direct clinical supervision.
Visual Packaging Elements: The medicine is sealed in a silver metallic aluminum blister pack strip featuring blue brand labels, black textual printing, an tracking inventory barcode sticker, and a prominent red warning block indicating its status as a controlled medical substance.
6. Manufacturer Information
Manufactured in India By: Sun Pharma Laboratories Ltd.
Manufacturing Plant Address: Vill. Kokjhar, Mirza Palasbari Road, P.O.: Palasbari, Dist.: Kamrup, Assam-781128.
7. Marketed By
Marketed By: Sun Pharma Laboratories Ltd.